Biopharmaceutical Cold Chain Logistics Market Forecast 2026: Market Size, Competitive Landscape And Growth Drivers
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Biopharmaceutical Cold Chain Logistics Market Set To Climb From $18 Billion In 2026 To $25.87 Billion By 2030
The biopharmaceutical cold chain logistics market has seen substantial growth in recent years. It is forecast to expand from $16.47 billion in 2025 to $18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.3%. This historical development can be attributed to factors such as increasing biopharmaceutical production, higher demands for vaccine distribution, the expansion of clinical trial logistics, the development of refrigerated transport networks, and the implementation of passive insulated packaging.
The biopharmaceutical cold chain logistics market size is anticipated to demonstrate substantial growth in the next few years. It is projected to reach $25.87 billion in 2030, expanding at a compound annual growth rate (CAGR) of 9.5%. This expansion during the forecast period is driven by factors such as the increasing implementation of active temperature-controlled containers, the heightened demand for cold chain monitoring services, the growing utilization of reusable thermal packaging, the broadening of short-term transit storage solutions, and the deeper integration with AI and IoT-enabled logistics systems. Noteworthy developments expected in this timeframe involve the greater adoption of temperature-controlled packaging solutions, the rising need for last-mile cold chain delivery, the increasing incorporation of real-time cold chain monitoring, the enlargement of refrigerated and cryogenic storage facilities, and an elevated focus on compliance and regulatory support services.
Get A Free Sample Report With In-Depth Market Insights:
Biopharmaceutical Cold Chain Logistics Market Growth Factors Behind Sustained Expansion
The biopharmaceutical cold chain logistics market is projected to expand in the future due to the rising demand for personalized medicine. Personalized medicine is a strategy that customizes healthcare and treatments based on an individual patient’s distinct biological and personal characteristics. The utilization of personalized medicine is increasing, driven by developments in genomic technologies, which enable healthcare providers to analyze a patient’s genetic information swiftly and accurately, thereby facilitating more targeted and effective therapies. Biopharmaceutical cold chain logistics supports personalized medicine by maintaining the necessary temperature and handling conditions for individualized treatments, guaranteeing their effectiveness and safety until they are delivered to patients. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. The personalized treatments newly approved in 2023 also comprised seven cancer drugs and three for other diseases and conditions. Therefore, the growing demand for personalized medicine is propelling the growth of the biopharmaceutical cold chain logistics market.
Biopharmaceutical Cold Chain Logistics Market Segment Trends And Revenue Contributors
The biopharmaceutical cold chain logistics market covered in this report is segmented –
1) By Service Type: Transportation, Storage, Packaging, Other Service Types
2) By Product Type: Vaccines, Clinical Trial Materials, Biopharmaceuticals, Other Product Types
3) By Temperature Range: Refrigerated, Frozen, Cryogenic, Other Temperature Ranges
4) By Mode Of Transportation: Airways, Roadways, Seaways, Railways
5) By End-User: Pharmaceutical And Biotechnology Companies, Healthcare Providers, Research Institutes, Other End Users
Subsegments:
1) By Transportation: Refrigerated Road Transport, Temperature Controlled Air Freight, Insulated Sea Freight, Last Mile Cold Delivery
2) By Storage: Refrigerated Warehousing, Frozen Storage Facilities, Cryogenic Storage, Short Term Transit Storage
3) By Packaging: Passive Insulated Packaging, Active Temperature Controlled Containers, Reusable Thermal Packaging, Single Use Cold Chain Packaging
4) By Other Service Types: Cold Chain Monitoring Services, Validation And Qualification Services, Inventory Management Services, Regulatory Compliance Support Services
Biopharmaceutical Cold Chain Logistics Market Industry Trends Fueling Future Revenue Growth
Major companies within the biopharmaceutical cold chain logistics market are concentrating on developing innovative solutions, such as reusable temperature-controlled pallet shippers, to ensure the safe, sustainable, and cost-efficient transportation of temperature-sensitive biologics. A reusable temperature-controlled pallet shipper is a durable, multi-use container designed to maintain stable temperatures for securely transporting sensitive biopharmaceuticals. For instance, in April 2025, Cold Chain Technologies LLC, a US-based packaging company, launched the reusable CCT Tower Elite, a 1600 L temperature-controlled pallet shipper specifically designed for life sciences logistics, which includes integrated IoT for real-time monitoring. This shipper is engineered to maintain stability for over 120 hours at temperatures such as <-60°C, +5°C, and +20°C through the use of phase-change materials, thereby supporting vaccines, biologics, and gene therapies in formats like RoSS® shells and API drums. Its lightweight, aircraft-compatible construction and global reuse network contribute to enhanced sustainability in pharmaceutical shipments.
Biopharmaceutical Cold Chain Logistics Market Leading Companies And Competitive Benchmarking
Major companies operating in the biopharmaceutical cold chain logistics market are Cencora Inc., DHL Group, United Parcel Service of America Inc., FedEx Corporation, A.P. Møller – Mærsk A/S, SF Holding Co. Ltd., Schenker AG, CEVA Logistics S.A., Nippon Express Holdings Inc., GXO Logistics Inc., Sonoco Products Company, Agility Public Warehousing Company K.S.C.P., Americold Realty Trust Inc., Marken Ltd., Pelican Products Inc., Cold Chain Technologies LLC, Controlant hf., Sensitech Inc., Envirotainer AB, QuickSTAT Global Life Science Logistics LLC, Cryopak Industries Inc., DGP Intelsius Ltd., Tower Cold Chain Solutions Ltd., and Snowman Logistics Limited.
View The Full Biopharmaceutical Cold Chain Logistics Market Report:
Biopharmaceutical Cold Chain Logistics Market Largest Region By Revenue And Market Share
North America was the largest region in the biopharmaceutical cold chain logistics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cold chain logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
